Immunization of mice with inactivated polio vaccine (IPV) with concurrent dosing of poliovirus antiviral V-073 showed no detrimental impact on the elicitation of serum-neutralizing antibodies. A strategy involving coadministration of antiviral V-073 and IPV can be considered for the management of poliovirus incidents.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3147355 | PMC |
http://dx.doi.org/10.1128/CVI.05147-11 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!